These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16951234)

  • 1. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
    Bianco C; Strizzi L; Mancino M; Rehman A; Hamada S; Watanabe K; De Luca A; Jones B; Balogh G; Russo J; Mailo D; Palaia R; D'Aiuto G; Botti G; Perrone F; Salomon DS; Normanno N
    Clin Cancer Res; 2006 Sep; 12(17):5158-64. PubMed ID: 16951234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
    Mancino M; Strizzi L; Wechselberger C; Watanabe K; Gonzales M; Hamada S; Normanno N; Salomon DS; Bianco C
    J Cell Physiol; 2008 Apr; 215(1):192-203. PubMed ID: 17941089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRIPTO-1: a novel target for therapeutic intervention in human carcinoma.
    Normanno N; De Luca A; Maiello MR; Bianco C; Mancino M; Strizzi L; Arra C; Ciardiello F; Agrawal S; Salomon DS
    Int J Oncol; 2004 Oct; 25(4):1013-20. PubMed ID: 15375551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunohistochemical detection of amphiregulin and cripto in human normal colon and colorectal tumors.
    Saeki T; Stromberg K; Qi CF; Gullick WJ; Tahara E; Normanno N; Ciardiello F; Kenney N; Johnson GR; Salomon DS
    Cancer Res; 1992 Jun; 52(12):3467-73. PubMed ID: 1596904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice.
    Kenney NJ; Smith GH; Maroulakou IG; Green JH; Muller WJ; Callahan R; Salomon DS; Dickson RB
    Mol Carcinog; 1996 Jan; 15(1):44-56. PubMed ID: 8561865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells.
    Hampton R; Walker M; Marshall J; Juhl H
    Oncogene; 2002 Nov; 21(51):7817-23. PubMed ID: 12420218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
    Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma DNA measurement as a biomarker of cancer].
    Czeiger D; Agassi R; Sebbag G; Zlotnik A; Douvdevani A; Shaked G
    Harefuah; 2014 Oct; 153(10):569-72, 625. PubMed ID: 25518072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.
    Adkins HB; Bianco C; Schiffer SG; Rayhorn P; Zafari M; Cheung AE; Orozco O; Olson D; De Luca A; Chen LL; Miatkowski K; Benjamin C; Normanno N; Williams KP; Jarpe M; LePage D; Salomon D; Sanicola M
    J Clin Invest; 2003 Aug; 112(4):575-87. PubMed ID: 12925698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N; De Luca A; Bianco C; Maiello MR; Carriero MV; Rehman A; Wechselberger C; Arra C; Strizzi L; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Jan; 198(1):31-9. PubMed ID: 14584041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor-related proteins in the aged adult mouse mammary gland and their relationship to tumorigenesis.
    Herrington EE; Ram TG; Salomon DS; Johnson GR; Gullick WJ; Kenney N; Hosick HL
    J Cell Physiol; 1997 Jan; 170(1):47-56. PubMed ID: 9012784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells.
    Watanabe K; Meyer MJ; Strizzi L; Lee JM; Gonzales M; Bianco C; Nagaoka T; Farid SS; Margaryan N; Hendrix MJ; Vonderhaar BK; Salomon DS
    Stem Cells; 2010 Aug; 28(8):1303-14. PubMed ID: 20549704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas.
    Hong SP; Lee EK; Park JY; Jeon TJ; Bang S; Park S; Chung JB; Lee WJ; Kim H; Song SY
    Oncol Rep; 2009 Jan; 21(1):19-24. PubMed ID: 19082438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of Cripto-1 expression by a hammerhead-shaped RNA molecule results from inhibition of translation rather than mRNA cleavage.
    Kintner RL; Hosick HL
    Biochem Biophys Res Commun; 1998 Apr; 245(3):774-9. PubMed ID: 9588190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
    D'Antonio A; Losito S; Pignata S; Grassi M; Perrone F; De Luca A; Tambaro R; Bianco C; Gullick WJ; Johnson GR; Iaffaioli VR; Salomon DS; Normanno N
    Int J Oncol; 2002 Nov; 21(5):941-8. PubMed ID: 12370739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families.
    De Angelis E; Grassi M; Gullick WJ; Johnson GR; Rossi GB; Tempesta A; De Angelis F; De Luca A; Salomon DS; Normanno N
    Int J Oncol; 1999 Mar; 14(3):437-40. PubMed ID: 10024674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors.
    Baldassarre G; Tucci M; Lembo G; Pacifico FM; Dono R; Lago CT; Barra A; Bianco C; Viglietto G; Salomon D; Persico MG
    Tumour Biol; 2001; 22(5):286-93. PubMed ID: 11553858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.